Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT01972360
Eligibility Criteria:
Inclusion Criteria:
* clinically indicated request for SPECT
* ability to undergo at least one of three non-nuclear imaging tests; CMR, CT or Stress Echocardiography
* History of recent symptoms suggestive of myocardial ischemia
* High risk for ischemic cardiovascular events
Exclusion Criteria:
* severely reduced systolic function (LV ejection fraction less than 35%)
* Recent (less than 3 days) acute coronary syndrome including acute myocardial infarction
* contraindications to dipyridamole SPECT including : i)severe reactive airway disease; ii) less than 3 days post Myocardial Infarction - Acute Coronary Syndrome (MI-ACS); iii) high-grade Atrioventricular block (AV block); iv)allergy to dipyridamole or theophylline; v) caffeine within 12 hours; vi) theophylline use within 48 hours; vii) severe claustrophobia; or viii) women who may be pregnant
* kidney dysfunction (i.e estimated Glomerular Filtration Rate (eGFR) less than 45)
* use of investigational drug or device within 30 days of screening visit
* Coronary Artery Bypass Graft(s) surgery (CABG)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
87 Years
Study:
NCT01972360
Study Brief:
Protocol Section:
NCT01972360